Market Tracker

08/20 6:05pm ET

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

168.74
Data as of Aug 20
 -1.02 / -0.60%
Today’s Change
100.89
Today|||52-Week Range
185.43
+26.98%
Year-to-Date

Today’s Trading

Previous close169.76
Today’s open168.45
Day’s range167.55 - 169.91
Volume743,337
Average volume (3 months)1,189,550
Market cap$33.6B
Dividend yield--
Data as of 3:59pm ET, 08/20/2014

Growth & Valuation

Earnings growth (last year)-0.78%
Earnings growth (this year)+62.98%
Earnings growth (next 5 years)+28.55%
Revenue growth (last year)+34.85%
P/E ratio85.2
Price/Sales17.19
Price/Book14.04

Competitors

 Today’s
change
Today’s
% change
VRXValeant Pharmaceutic...-0.62-0.55%
VRTXVertex Pharmaceutica...-0.62-0.67%
PRGOPerrigo Company PLC-1.41-0.93%
AGNAllergan Inc+1.31+0.81%
Data as of 4:05pm ET, 08/20/2014

Financials

Next reporting dateOctober 23, 2014
EPS forecast (this quarter)$1.16
Annual revenue (last year)$1.5B
Annual profit (last year)$252.9M
Net profit margin16.73%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, Treasurer &
Director
Leonard Bell
Chief Global Operations Officer &
Executive VP
Stephen P. Squinto
Corporate headquarters
Cheshire, Connecticut

Forecasts